US Broker Ratings

Integra LifeSciences Holdings (IART): Navigating Opportunities with a 16% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART) presents a fascinating mix of opportunities and challenges for investors in the healthcare sector. As a key player in the..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Balancing Act with a 19.59% Upside Potential

Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling case for investors who are attuned to the dynamics of the healthcare sector, particularly within the realm of..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring a 125% Potential Upside Amidst Biotech Innovations

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage company focused on developing novel therapeutics for rare endocrine diseases, offers a compelling investment proposition with a remarkable potential..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Exploring Growth Potential with Innovative Biopharmaceuticals

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) is carving a niche in the biopharmaceutical landscape with its focus on developing and commercializing treatments for rare diseases and cancer...

MannKind Corporation (MNKD) Stock Analysis: Uncovering a 135% Potential Upside in Biotech Innovations

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, is catching the attention of investors with a compelling growth narrative and a significant potential..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Navigating Growth in the Healthcare Sector

Healthcare Services Group, Inc. (NASDAQ: HCSG), a company with a market capitalization of $1.07 billion, occupies a significant position within the healthcare sector, specifically in the..

Select Medical Holdings Corp (SEM) Stock Analysis: A 32% Upside and Strong Buy Ratings Signal Growth Potential

Select Medical Holdings Corporation (NYSE: SEM) stands out in the healthcare sector with a promising growth trajectory that appeals to investors seeking opportunities in medical care..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: 34.89% Potential Upside Captures Investor Attention

For investors eyeing opportunities in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) offers a compelling proposition. With a market capitalization of $1.19 billion, this..

Opko Health, Inc. (OPK) Stock Analysis: A Healthcare Play with 189% Potential Upside

Opko Health, Inc. (NASDAQ: OPK) stands out in the healthcare sector with its diversified operations in diagnostics and pharmaceuticals. Despite facing challenges with revenue growth and..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 29.90% Potential Upside in the Dynamic Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a pioneering force in the healthcare industry, has been capturing the attention of investors with its innovative approach to cardiovascular care...

Neogen Corporation (NEOG) Stock Analysis: Exploring a 63% Potential Upside for Investors

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector’s diagnostics and research industry, presents a compelling opportunity for investors eyeing substantial potential upside. With..

Artivion, Inc. (AORT) Stock Analysis: Navigating Potential Upside in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the medical devices industry, is catching the eye of investors with its potential upside of 10.77%, as indicated..

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Exploring a 21.71% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, specializes in the development and distribution of both generic and proprietary injectable, inhalation, and..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 21.32% Potential Upside for Investors

Pediatrix Medical Group, Inc. (NASDAQ: MD), a prominent player in the healthcare sector, is turning heads with a compelling potential upside of 21.32%, according to the..

Ligand Pharmaceuticals (LGND) Stock Analysis: Unveiling a 31% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is capturing significant attention in the biotechnology sector, driven by its robust pipeline and promising market positioning. With a market capitalization..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating a 28% Potential Upside for Investors

Investors seeking opportunities in the healthcare sector may find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing option. Despite its current challenges, the company presents a notable..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Navigating the Future of Bioelectric Medicine with an Eye on Growth Potential

Pulse Biosciences, Inc. (NASDAQ: PLSE), a formidable player in the healthcare sector, is making waves in the medical instruments and supplies industry with its pioneering bioelectric..

89bio, Inc. (ETNB) Stock Analysis: Exploring a Potential 178% Upside in the Biotech Market

89bio, Inc. (NASDAQ: ETNB), a promising player in the biotechnology sector, has caught the attention of investors with its ambitious approach to addressing liver and cardio-metabolic..

Novavax, Inc. (NVAX) Stock Analysis: Intriguing Potential with Nearly 98% Upside

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, is captivating investor attention with its substantial growth potential. The company, based in Gaithersburg, Maryland,..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 95.69% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a notable player in the biotechnology sector, stands out with a remarkable potential upside of 95.69% based on current analyst ratings...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds